ICLR
Price
$306.58
Change
+$8.65 (+2.90%)
Updated
Apr 23, 1:30 PM EST
One day until earnings call
WST
Price
$390.10
Change
+$14.64 (+3.90%)
Updated
Apr 23, 1:51 PM EST
2 days until earnings call
Ad is loading...

Compare trend and price ICLR vs WST

Header iconICLR vs WST Comparison
Open Charts ICLR vs WSTBanner chart's image
ICON
Price$306.58
Change+$8.65 (+2.90%)
Volume$100
CapitalizationN/A
West Pharmaceutical Services
Price$390.10
Change+$14.64 (+3.90%)
Volume$200
CapitalizationN/A
View a ticker or compare two or three
ICLR vs WST Comparison Chart

Loading...

ICLRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
WSTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ICLR vs. WST commentary
Apr 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICLR is a Hold and WST is a Hold.

COMPARISON
Comparison
Apr 23, 2024
Stock price -- (ICLR: $297.93 vs. WST: $375.35)
Brand notoriety: ICLR and WST are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ICLR: 150% vs. WST: 114%
Market capitalization -- ICLR: $27.35B vs. WST: $28.97B
ICLR [@Medical Specialties] is valued at $27.35B. WST’s [@Medical Specialties] market capitalization is $28.97B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICLR’s FA Score shows that 1 FA rating(s) are green whileWST’s FA Score has 1 green FA rating(s).

  • ICLR’s FA Score: 1 green, 4 red.
  • WST’s FA Score: 1 green, 4 red.
According to our system of comparison, ICLR is a better buy in the long-term than WST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ICLR’s TA Score shows that 3 TA indicator(s) are bullish while WST’s TA Score has 3 bullish TA indicator(s).

  • ICLR’s TA Score: 3 bullish, 5 bearish.
  • WST’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ICLR is a better buy in the short-term than WST.

Price Growth

ICLR (@Medical Specialties) experienced а -0.40% price change this week, while WST (@Medical Specialties) price change was -0.91% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.55%. For the same industry, the average monthly price growth was -2.75%, and the average quarterly price growth was +17.02%.

Reported Earning Dates

ICLR is expected to report earnings on Jul 24, 2024.

WST is expected to report earnings on Jul 25, 2024.

Industries' Descriptions

@Medical Specialties (+1.55% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for ICLR with price predictions.
OPEN
A.I.dvisor published
a Summary for WST with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
WST($29B) has a higher market cap than ICLR($27.4B). WST has higher P/E ratio than ICLR: WST (50.25) vs ICLR (44.81). WST YTD gains are higher at: 6.655 vs. ICLR (5.250). ICLR has higher annual earnings (EBITDA): 1.52B vs. WST (844M). WST has more cash in the bank: 854M vs. ICLR (380M). WST has less debt than ICLR: WST (309M) vs ICLR (3.94B). ICLR has higher revenues than WST: ICLR (8.12B) vs WST (2.95B).
ICLRWSTICLR / WST
Capitalization27.4B29B94%
EBITDA1.52B844M180%
Gain YTD5.2506.65579%
P/E Ratio44.8150.2589%
Revenue8.12B2.95B275%
Total Cash380M854M44%
Total Debt3.94B309M1,274%
FUNDAMENTALS RATINGS
ICLR vs WST: Fundamental Ratings
ICLR
WST
OUTLOOK RATING
1..100
5354
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
2428
SMR RATING
1..100
8246
PRICE GROWTH RATING
1..100
4854
P/E GROWTH RATING
1..100
3556
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ICLR's Valuation (73) in the Pharmaceuticals Other industry is in the same range as WST (85) in the Medical Specialties industry. This means that ICLR’s stock grew similarly to WST’s over the last 12 months.

ICLR's Profit vs Risk Rating (24) in the Pharmaceuticals Other industry is in the same range as WST (28) in the Medical Specialties industry. This means that ICLR’s stock grew similarly to WST’s over the last 12 months.

WST's SMR Rating (46) in the Medical Specialties industry is somewhat better than the same rating for ICLR (82) in the Pharmaceuticals Other industry. This means that WST’s stock grew somewhat faster than ICLR’s over the last 12 months.

ICLR's Price Growth Rating (48) in the Pharmaceuticals Other industry is in the same range as WST (54) in the Medical Specialties industry. This means that ICLR’s stock grew similarly to WST’s over the last 12 months.

ICLR's P/E Growth Rating (35) in the Pharmaceuticals Other industry is in the same range as WST (56) in the Medical Specialties industry. This means that ICLR’s stock grew similarly to WST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ICLRWST
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 7 days ago
50%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
57%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
56%
Advances
ODDS (%)
N/A
Bullish Trend 23 days ago
74%
Declines
ODDS (%)
Bearish Trend 5 days ago
57%
Bearish Trend 5 days ago
53%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
59%
View a ticker or compare two or three
Ad is loading...
ICLRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
WSTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EXFY1.700.06
+3.66%
Expensify
CDP23.040.27
+1.19%
COPT Defense Properties
PNR79.200.67
+0.85%
Pentair plc
CGEM15.63-0.03
-0.19%
Cullinan Therapeutics
NTBL0.95-0.03
-2.56%
Notable Labs Ltd

ICLR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICLR has been closely correlated with IQV. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if ICLR jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICLR
1D Price
Change %
ICLR100%
+3.37%
IQV - ICLR
68%
Closely correlated
+1.42%
RGEN - ICLR
62%
Loosely correlated
+0.22%
CRL - ICLR
58%
Loosely correlated
+2.55%
MEDP - ICLR
51%
Loosely correlated
+1.15%
VCYT - ICLR
46%
Loosely correlated
+2.06%
More

WST and

Correlation & Price change

A.I.dvisor indicates that over the last year, WST has been loosely correlated with EW. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if WST jumps, then EW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WST
1D Price
Change %
WST100%
+0.89%
EW - WST
42%
Loosely correlated
+1.19%
IDXX - WST
40%
Loosely correlated
+0.68%
STVN - WST
40%
Loosely correlated
-0.71%
IQV - WST
38%
Loosely correlated
+1.42%
DHR - WST
38%
Loosely correlated
+0.24%
More